Did narcolepsy occur following administration of AS03-adjuvanted A(H1N1) pandemic vaccine in Ontario, Canada? A review of post-marketing safety surveillance data. [electronic resource]
Producer: 20151123ISSN:- 1560-7917
- Adjuvants, Immunologic -- administration & dosage
- Female
- Humans
- Infant
- Influenza A Virus, H1N1 Subtype -- immunology
- Influenza Vaccines -- administration & dosage
- Influenza, Human -- epidemiology
- Male
- Middle Aged
- Narcolepsy -- epidemiology
- Ontario -- epidemiology
- Pandemics -- prevention & control
- Product Surveillance, Postmarketing
- Sentinel Surveillance
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.